Empros Pharma is an innovative pharmaceutical company founded in 2013 by senior researchers and entrepreneurs from Uppsala University, along with external investor Flerie Invest. With a strong focus on weight management, Empros Pharma directs all investments towards the advancement of their cutting-edge drug project. The company is agile and dedicated, continuously striving for progress.

Empros Pharma envisions a world where obesity is not seen as an individual's fault and where personalized treatment is accessible to all. By addressing the lack of available medication in the field of obesity medicine, Empros Pharma aims to be a game changer, positively impacting individuals worldwide. Trust and transparency are key values at Empros Pharma.

The company carefully selects external professionals and fosters a culture of inclusion, considering every team member's role as vital. They believe in sharing information and ideas, relying on the skills and knowledge of each individual to drive the company forward. With Empros Pharma, the future of weight management and improved health is within reach